COVID-19 vaccination in Zimbabwe

Last updated

COVID-19 vaccination in Zimbabwe
Date22 February 2021–present
LocationZimbabwe
Cause COVID-19 pandemic
Organised by Ministry of Health and Child Care (Zimbabwe)
Participants
  • 6,437,808 [1] (total vaccinated)
  • 4,751,270 [1] (fully vaccinated)
  • 12,222,754 [1] (doses administered)
Outcome

41.5% of the Zimbabwean population received at least one dose [2]

Contents

  


30.2% of the Zimbabwean population fully vaccinated [2]

  

As of 11 June 2022

On 22 February 2021, Zimbabwe launched their national COVID-19 vaccination program using the Sinopharm BIBP vaccine. [3] [4] As of 17 June 2022, 6,260,228 people have received their first dose, 4,598,703 have received their second dose, and 851,874 have received a third dose. [5]

Corruption is alleged to exist within the public vaccination program, with priority for receiving vaccines being given to those willing to pay bribes to hospital staff, and members of Zimbabwe's ruling party ZANU-PF. Vaccines are reportedly available within the private health care system at a cost of approximately US$40. [6]

Vaccine in order

VaccineApprovalDeployment
Sinopharm BIBP Green check.svg YesGreen check.svg Yes
Covaxin Green check.svg YesDark Red x.svg No
Sinovac Green check.svg YesDark Red x.svg No
Sputnik V Green check.svg YesDark Red x.svg No

History

Timeline

On 14 February 2021, the first 200,000 doses of the Sinopharm BIBP vaccine landed at Harare's Robert Mugabe International Airport. [7] [8]

On 22 February 2021 Zimbabwe began its vaccination program. [9]

On 25 February the number of people vaccinated surpassed 10,000 people. [10]

In mid-June 2021, Alrosa Zim donated 25,000 doses of the Sputnik V COVID-19 vaccine to Zimbabwe, followed by 25,000 more doses a month later. [11]

On 8 July 2021, Zimbabwe received 2 million doses of the Sinovac vaccine. [12]

In December 2021, a booster vaccination programme was launched for those already double vaccinated. [13]

On 20 December 2021, Zimbabwe received one million doses of the Sinovac vaccine donated by China.

Progress

By the end of March 2021, 85,866 vaccine doses had been administered; 433,939 by the end of April; one million by the end of May; 1.3 million by the end of June; 2.3 million by the end of July; 3.8 million by the end of August; 5.2 million by the end of September; 5.8 million by the end of October; 6.4 million by the end of November; 7.2 million by the end of December 2021; 7.8 million by the end of January 2022; 7.9 million by the end of February 2022; 9.4 million by the end of March 2022; 10.3 million by the end of April 2022.

There were 0.8 million fully vaccinated by the end of July 2021; 1.6 million by the end of August; 2.3 million by the end of September 2021; 2.5 million by the end of October 2021; 2.8 million by the end of November 2021; 3.1 million by the end of December 2021; 3.3 million by the end of January 2022; 3.4 million by the end of February 2022; 3.5 million by the end of March 2022; 3.7 million by the end of April 2022.

Cumulative COVID-19 vaccine doses administered in Zimbabwe
  1st dose
  2nd dose
  3rd dose
Daily doses administered in Zimbabwe
  1st dose
  2nd dose
  3rd dose

Related Research Articles

<span class="mw-page-title-main">Sinovac Biotech</span> Chinese biopharmaceutical company

Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China.

<span class="mw-page-title-main">COVID-19 pandemic in Benin</span> Ongoing COVID-19 viral pandemic in Benin

The COVID-19 pandemic in Benin was a part of the ongoing worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Benin in March 2020.

<span class="mw-page-title-main">COVID-19 pandemic in Zimbabwe</span> Ongoing COVID-19 viral pandemic in Zimbabwe

The COVID-19 pandemic in Zimbabwe is part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 .The COVID-19 pandemic was confirmed to have reached Zimbabwe in March 2020. Some of Zimbabwe's provinces, especially Manicaland, Masvingo and Mashonaland East, also struggled with a malaria outbreak at the same time. Though malaria is treatable, the healthcare system faces drug shortages and increased strain with the spread of COVID-19.

<span class="mw-page-title-main">Vaccine diplomacy</span> Use of vaccines as international diplomacy

Vaccine diplomacy, a form of medical diplomacy, is the use of vaccines to improve a country's diplomatic relationship and influence of other countries. Meanwhile, vaccine diplomacy also "means a set of diplomatic measures taken to ensure access to the best practices in the development of potential vaccines, to enhance bilateral and/or multilateral cooperation between countries in conducting joint R&D, and, in the case of the announcement of production, to ensure the signing of a contract for the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part in the distribution of the smallpox vaccine.

<span class="mw-page-title-main">COVAX</span> Initiative to provide COVID-19 vaccines

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO), alongside key delivery partner UNICEF. It is one of the four pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well as logistics, country readiness and in-country delivery.

<span class="mw-page-title-main">Sinopharm BIBP COVID-19 vaccine</span> Vaccine against COVID-19

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm's Beijing Institute of Biological Products. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants. BBIBP-CorV shares similar technology with CoronaVac and Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine, not to be confused with the similar product name of CoronaVac.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Angola is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. As of 15 June 2021, Angola has administered 1,314,375 doses of vaccines.822,109 people with the first dose and 492,266 people fully vaccinated. Angola began their vaccination program shortly after receiving their first shipment of Oxford AstraZeneca vaccine in early March 2021.

On 23 February 2021, Senegal began its national vaccination program against the COVID-19. As of 10 March, 68,205 people in Senegal have been able to be vaccinated.

<span class="mw-page-title-main">COVID-19 vaccination in Africa</span> Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. In June 2021, the World Health Organization predicted that 47 of Africa's 54 nations would fall short of the aim of vaccinating 10% of their people by September 2021. In June, Africa accounted for fewer than 1% of worldwide vaccine doses delivered. Africa received in total less than 2% of the 3 billion vaccination doses provided globally.

<span class="mw-page-title-main">COVID-19 vaccination in Indonesia</span> Plan to immunize against COVID-19

The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks third in Asia and fifth in the world.

<span class="mw-page-title-main">COVID-19 vaccination in Nigeria</span> Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 28 February 2022, 17,914,944 people have received their first dose a COVID-19 vaccine, and 8,197,832 have received their second dose.

<span class="mw-page-title-main">COVID-19 vaccination in Bangladesh</span> Immunisation programme against COVID-19 in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

<span class="mw-page-title-main">COVID-19 vaccination in Singapore</span> Plan to immunize against COVID-19

The COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Singapore has a very high vaccination rate, with more than 92% of its total population having completed their vaccination regimen.

<span class="mw-page-title-main">COVID-19 vaccination in Sri Lanka</span> Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX.

COVID-19 vaccination in Egypt is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Equatorial Guinea is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in mainland China</span> Plan to immunize against COVID-19

COVID-19 vaccination in mainland China is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in mainland China, in response to the ongoing pandemic in the region.

Vaccination against COVID-19 in Portugal started on 27 December 2020.

References

  1. 1 2 3 Ritchie, Hannah; Mathieu, Edouard; Rodés-Guirao, Lucas; Appel, Cameron; Giattino, Charlie; Ortiz-Ospina, Esteban; Hasell, Joe; Macdonald, Bobbie; Beltekian, Diana; Dattani, Saloni; Roser, Max (2020–2022). "Coronavirus Pandemic (COVID-19)". Our World in Data . Retrieved 18 May 2023.
  2. 1 2 Ritchie, Hannah; Mathieu, Edouard; Rodés-Guirao, Lucas; Appel, Cameron; Giattino, Charlie; Ortiz-Ospina, Esteban; Hasell, Joe; MacDonald, Bobbie; Beltekian, Diana; Roser, Max (5 March 2020). "Coronavirus (COVID-19) Vaccinations". Our World in Data. Retrieved 14 April 2021.
  3. ↑ "Zimbabwe starts Covid-19 vaccinations, Vice President Chiwenga gets first shot". News24. Retrieved 5 March 2021.
  4. ↑ "Zimbabwe expected to begin COVID-19 vaccinations on Thursday". SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader. 17 February 2021. Retrieved 5 March 2021.
  5. ↑ Ministry of Health and Child Care [@MoHCCZim] (17 June 2022). "COVID-19 update: As at 17 June 2022, Zimbabwe had 254 753 confirmed cases, including 247 379 recoveries and 5 533 deaths. To date, a total of 6 260 228 people have been vaccinated against COVID-19" (Tweet). Retrieved 18 June 2022– via Twitter.
  6. ↑ York, Geoffrey (5 August 2021). "Mounting desperation in Africa as COVID-19 vaccine shortage persists". The Globe and Mail. Harare and Johannesburg. Retrieved 5 August 2021.
  7. ↑ "WATCH: Zimbabweans react to Sinopharm COVID-19 vaccine | eNCA". www.enca.com. Retrieved 5 March 2021.
  8. ↑ News, Eyewitness. "First 200,000 coronavirus vaccines en route to Zimbabwe". ewn.co.za. Retrieved 5 March 2021.{{cite web}}: |last= has generic name (help)
  9. ↑ "Zimbabwe begins vaccine rollout with Sinopharm jabs | eNCA". www.enca.com. Retrieved 5 March 2021.
  10. ↑ @MoHCCZim (25 February 2021). "COVID-19 update: As at 25 February 2021, Zimbabwe had 35 994 confirmed cases, including 32 455 recoveries and 1 458 deaths" (Tweet). Retrieved 14 April 2021– via Twitter.
  11. ↑ "25 000 more doses arrive from Russia". The Herald. 15 July 2021. Retrieved 15 July 2021.
  12. ↑ "Zimbabwe gets 2 million Sinovac doses to boost Covid-19 vaccination". News24. Retrieved 9 July 2021.
  13. ↑ "Covid-19: Schools to remain open... booster shots start". The Sunday News. 5 December 2021. Retrieved 5 December 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.